CSPC Innovation Pharmaceutical (300765.SZ) completed a repurchase of 12.002 million shares at a cost of 321 million yuan.
New Noble (300765.SZ) announcement, as of September 20, 2024, the company has completed the share repurchase through special certificates...
CSPC Innovation Pharmaceutical (300765.SZ) announced that as of September 20, 2024, the company repurchased 12.002 million shares of the company through a special securities account for share repurchase using centralized bidding trading, accounting for 0.85% of the company's current total share capital. The highest transaction price was 34.99 yuan per share, the lowest transaction price was 18.68 yuan per share, and the total amount paid was 321 million yuan (excluding transaction costs). The buyback period has expired, and the buyback plan has been completed.
Related Articles

US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.

US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%

US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.
US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.

US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%

US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.

RECOMMEND

Rare Sales Decline for Tank Brand—How Will Great Wall Motor Defend Its Market Position?
14/07/2025

Inside the Explosive Growth of the New Tea Beverage Sector: Supply Chains, Innovation, and Cultural Capital
14/07/2025

Hafu Securities Joins the Race as Hong Kong Accelerates Its Push to Become a Virtual Asset Hub
14/07/2025